Literature DB >> 13231051

Ascorbic acid level in leukemic patients.

A L WALDO, R E ZIPF.   

Abstract

Entities:  

Keywords:  BLOOD; LEUKEMIA/blood in; VITAMIN C/in blood

Mesh：

Substances：

Year:  1955        PMID： 13231051     DOI： 10.1002/1097-0142(1955)8:1<187::aid-cncr2820080126>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Distribution of ascorbic acid in normal and leukaemic human blood.

Authors:  P BARKHAN; A N HOWARD
Journal:  Biochem J       Date:  1958-09       Impact factor: 3.857

2.  Platelet ascorbic acid levels in normal subjects and in disease.

Authors:  J V Lloyd; P S Davis; H Emery; H Lander
Journal:  J Clin Pathol       Date:  1972-06       Impact factor: 3.411

3.  Plasma and leucocyte ascorbic acid concentrations in acute lymphoblastic leukaemia.

Authors:  S C Kakar; C W Wilson; J N Bell
Journal:  Ir J Med Sci       Date:  1975-12       Impact factor: 1.568

4.  NAD(P)H: quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes.

Authors:  Archita Das; Neekkan Dey; Arunava Ghosh; Tanusree Das; Indu B Chatterjee
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

5.  Patients Undergoing Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation Exhibit Depleted Vitamin C Status in Association with Febrile Neutropenia.

Authors:  Anitra C Carr; Emma Spencer; Andrew Das; Natalie Meijer; Carolyn Lauren; Sean MacPherson; Stephen T Chambers
Journal:  Nutrients       Date:  2020-06-24       Impact factor: 5.717

6.  Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes.

Authors:  Linn Gillberg; Andreas D Ørskov; Ammar Nasif; Hitoshi Ohtani; Zachary Madaj; Jakob W Hansen; Nicolas Rapin; Johanne B Mogensen; Minmin Liu; Inge H Dufva; Jens Lykkesfeldt; Petra Hajkova; Peter A Jones; Kirsten Grønbæk
Journal:  Clin Epigenetics       Date:  2019-10-17       Impact factor: 6.551

Review 7.  Differentiation therapy of myeloid leukemia: four decades of development.

Authors:  Vikas Madan; H Phillip Koeffler
Journal:  Haematologica       Date:  2021-01-01       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.